In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
University of Virginia
Mayo Clinic
Ohio State University Comprehensive Cancer Center
University of Florida
University of Zurich
Vanderbilt-Ingram Cancer Center
University of Southern California
Yale University